Brind.
  1. Pfizer, Merck, and Amgen are large-cap drugmakers with significant operations in the United States.

Amgen and Merck are currently competing against each other in the market for investor capital.

4 reports, 2 independent Updated Oct 15
Gone quiet Reached 3 outlets in its first 24 hours
Reports
4
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Amgen and Merck are currently competing against each other in the market for investor capital.

Who's involved

What this event is mainly about
AmgenMerck

How it developed

Newest first. Tap a step to see who reported it.
  1. Amgen's growth products surged while Merck's core growth turned negative.1 source
  2. Amgen and Merck are competing for investor capital.1 source

Keep exploring

Part of

Pfizer, Merck, and Amgen are large-cap drugmakers with significant operations in the United States. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
2 more outlets ran the same wire story